If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

A groundbreaking Cleveland Clinic trial is demonstrating how gene-editing technology could transform the way millions of Americans manage high cholesterol. A Phase 1 clinical trial at Cleveland Clinic ...

Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. It’s a surprisingly young ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

High cholesterol, or hypercholesterolemia, affects nearly 1 in 3 American adults—yet it often goes undetected until a serious event like a heart attack or stroke occurs. It's one of the major ...

New cholesterol guidelines advise doctors to begin screening and treating people in their 30s, long before the risks of a heart attack and stroke become significantly higher. For the first time, the ...

For the roughly 200 million people worldwide who take a statin every day, the routine is deceptively simple: swallow a pill, ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine hairpins, they increased cholesterol uptake by cells and reduced ...

Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. Subscribe to read this ...